Squarepoint’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Squarepoint’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.6K	Buy	26,468 +2,661	+11%	+$5.43K	﹤0.01%	4267
2026 Q1	$58.6K	Sell	23,807 -10,515	-31%	-$35.2K	﹤0.01%	4126
2025 Q4	$137K	Buy	34,322 +22,624	+193%	+$100K	﹤0.01%	3975
2025 Q3	$44.2K	Buy	+11,698	New	+$39.7K	﹤0.01%	4240
2023 Q4	–	Sell	-12,561	Closed	-$16.6K	–	4231
2023 Q3	$16.6K	Buy	+12,561	New	+$27.6K	﹤0.01%	3707
2023 Q1	–	Sell	-16,888	Closed	-$70.6K	–	3473
2022 Q4	$70.6K	Sell	16,888 -49,546	-75%	-$188K	﹤0.01%	3009
2022 Q3	$266K	Buy	66,434 +1,653	+3%	+$12.5K	﹤0.01%	2547
2022 Q2	$732K	Buy	+64,781	New	+$777K	﹤0.01%	1790
2022 Q1	–	Sell	-6,143	Closed	-$291K	–	3164
2021 Q4	$291K	Sell	6,143 -15,807	-72%	-$949K	﹤0.01%	2464
2021 Q3	$1.59M	Buy	21,950 +13,850	+171%	+$1M	﹤0.01%	1313
2021 Q2	$680K	Buy	+8,100	New	+$534K	﹤0.01%	1922

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint's NBP Position: Q2 2026 in Review

Squarepoint increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 11% in Q2 2026, buying an estimated $5.43K and bringing the position to 26,468 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4267.

Squarepoint first reported a position in NBP in Q2 2021 and has held it in 11 quarters since. The position peaked at $1.59M in Q3 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Squarepoint held 26,468 shares of NovaBridge Biosciences American Depositary Shares worth $51.6K as of Q2 2026.
Squarepoint bought 2,661 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $5.43K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4267 holding.
Squarepoint first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 11 quarters since.
Squarepoint's NovaBridge Biosciences American Depositary Shares position peaked at $1.59M in Q3 2021.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.